Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice
- PMID: 2790807
Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice
Abstract
The effects of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice have been investigated using a versatile procedure for encapsulating doxorubicin inside liposomes. In this procedure, vesicles exhibiting transmembrane pH gradients (acidic inside) were employed to achieve drug trapping efficiencies in excess of 98%. Drug-to-lipid ratios as high as 0.3:1 (wt:wt) could be obtained in a manner that is relatively independent of lipid composition and vesicle size. Egg phosphatidylcholine (EPC)/cholesterol (55:45; mol/mol) vesicles sized through filters with a 200-nm pore size and loaded employing transmembrane pH gradients to achieve a doxorubicin-to-lipid ratio of 0.3:1 (wt/wt) increased the LD50 of free drug by approximately twofold. Removing cholesterol or decreasing the drug-to-lipid ratio in EPC/cholesterol preparations led to significant decreases in the LD50 of liposomal doxorubicin whereas, the LD50 increased 4- to 6-fold when distearoylphosphatidylcholine was substituted for EPC. The results suggest that the stability of liposomally entrapped doxorubicin in the circulation is an important factor in the toxicity of this drug in liposomal form. In contrast, the antitumor activity of liposomal doxorubicin is not influenced dramatically by alterations in lipid composition. Liposomal doxorubicin preparations of EPC, EPC/cholesterol (55:45; mol:mol), EPC/egg phosphatidylglycerol (EPG)/cholesterol (27.5:27.5:45; mol:mol), and distearoylphosphatidylcholine/cholesterol (55:45; mol:mol) all demonstrated similar efficacy to that of free drug when given at doses of 20 mg/kg and below. Higher dose levels of the less toxic formulations could be administered, leading to enhanced increases in life span (ILS) values. Variations in vesicle size, however, strongly influenced the antitumor activity of liposomal doxorubicin. At a dose of 20 mg/kg, large EPC/cholesterol systems are significantly less effective than free drug (with ILS values of 65% and 145%, respectively). In contrast, small systems sized through filters with a 100-nm pore size are more effective than free drug, resulting in an ILS of 375% and a 30% long term (greater than 60 days) survival rate when administered at a dose of 20 mg/kg. Similar size-dependent effects are observed for distearoylphosphatidylcholine/cholesterol systems.
Similar articles
-
Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors.Cancer Res. 1990 Feb 1;50(3):575-9. Cancer Res. 1990. PMID: 2297698
-
Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes.Cancer Chemother Pharmacol. 1997;40(4):309-17. doi: 10.1007/s002800050662. Cancer Chemother Pharmacol. 1997. PMID: 9225948
-
Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients.Biochim Biophys Acta. 1990 Jun 27;1025(2):143-51. doi: 10.1016/0005-2736(90)90091-2. Biochim Biophys Acta. 1990. PMID: 2364073
-
Liposomal doxorubicin.J Drug Target. 1996;4(3):129-40. doi: 10.3109/10611869609015970. J Drug Target. 1996. PMID: 8959485 Review.
-
Use of liposomes as injectable-drug delivery systems.Am J Hosp Pharm. 1989 Aug;46(8):1576-87. Am J Hosp Pharm. 1989. PMID: 2672806 Review.
Cited by
-
The 60-year evolution of lipid nanoparticles for nucleic acid delivery.Nat Rev Drug Discov. 2024 Sep;23(9):709-722. doi: 10.1038/s41573-024-00977-6. Epub 2024 Jul 4. Nat Rev Drug Discov. 2024. PMID: 38965378 Review.
-
Translational Challenges and Prospective Solutions in the Implementation of Biomimetic Delivery Systems.Pharmaceutics. 2023 Nov 14;15(11):2623. doi: 10.3390/pharmaceutics15112623. Pharmaceutics. 2023. PMID: 38004601 Free PMC article. Review.
-
Lipid nanoparticle mRNA systems containing high levels of sphingomyelin engender higher protein expression in hepatic and extra-hepatic tissues.Mol Ther Methods Clin Dev. 2023 Jun 12;30:235-245. doi: 10.1016/j.omtm.2023.06.005. eCollection 2023 Sep 14. Mol Ther Methods Clin Dev. 2023. PMID: 37564393 Free PMC article.
-
Rapid short-pulses of focused ultrasound and microbubbles deliver a range of agent sizes to the brain.Sci Rep. 2023 Apr 28;13(1):6963. doi: 10.1038/s41598-023-33671-5. Sci Rep. 2023. PMID: 37117169 Free PMC article.
-
Liposomes in Cancer Therapy: How Did We Start and Where Are We Now.Int J Mol Sci. 2023 Apr 1;24(7):6615. doi: 10.3390/ijms24076615. Int J Mol Sci. 2023. PMID: 37047585 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources